CES treatment in PTSD should have a pronounced effect in that PTSD symptoms always increase when the person is under stress of any kind. Also, the research with CES in phobic patients indicates that phobic fear can not be experienced while CES treatment is in progress, and at least for a time thereafter. It is the panic felt by patients when the phobic areas are roused, with the accompanying uncontrolled system-wide sympathetic physiological arousal, that gives them their greatest fear and dread. To have CES
available during those times of panic should be very immediately helpful, and contribute markedly to a longer term cure as those feelings of helplessness dissipate or habituate via the continuing use of CES.

For this reason, it has been suggested that the use of CES during desensitization therapy, a therapy found very effective in treating PTSD, should allow desensitization therapy proceed at a much more rapid rate, and possibly be much more effective if it reduced or eliminated the fear while the desensitization was in process..

If nothing more, CES should reduce or eliminate many phobic areas within the personality, allowing the person to come down from his hyper aroused state and begin interacting in more areas of his life’s normal experience once again. That would be a type of desensitization therapy process on its own.

Clinical experience has shown that PTSD patients initially never go out without their CES device handy for use at a moment’s notice. The presence of the device gives them a needed feeling of security they can not get in any other way.

How much treatment is required to produce these effects with CES? Patients respond to differing amounts of CES treatment, depending on which of their neurohormonal systems CES is intended to rebalance. While effects begin to be felt from the first treatment, almost all patients are expected to come back within normal homeostatic limits with 30 minutes to 1 hour of treatments every day for 14 to 21 days, depending on the availability of any required neurohormonal precursors in their diet, their level of activity and so on.6

1. Jarzembski, W.B., S.J. Larson, and A. Sances Jr. (1970) “Eval
Following are key research abstracts that pertain to the prevalence of substance abuse in the US military and the need for non-drug therapies; conclusively proving that there now exist no conventional safe and effective alternatives; i.e. drugs for treating this condition:

Adler DA, Possemato K, Mavandadi S, Lerner D, Chang H, Klaus J, Tew JD, Barrett D, Ingram E, Oslin DW.
Psychiatric status and work performance of veterans of Operations Enduring Freedom and Iraqi Freedom. Psychiatr Serv. 2011 Jan;62(1):39-46.
Source: Department of Medicine, Tufts Medical Center, Boston, MA, USA.